Enavogliflozin trials for Type 2 diabetes

All Enavogliflozin trials · All Type 2 diabetes trials

Phase breakdown

Recruiting trials studying Enavogliflozin for Type 2 diabetes

• A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients
  NCT06642623 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
  NCT06782139 · Phase: Phase 4 · Ages: 20 Years to 79 Years · Sex: All (male and female) · 1 location
• Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
  NCT06399835 · Phase: Phase 4 · Ages: 20 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Enavogliflozin for Type 2 diabetes?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.